| Tuberculosis and COVID‐19: lessons from the past viral outbreaks and possible future outcomes R Crisan-Dabija, C Grigorescu, CA Pavel, B Artene, IV Popa, A Cernomaz, ... Canadian respiratory journal 2020 (1), 1401053, 2020 | 106 | 2020 |
| Using artificial intelligence resources in dialysis and kidney transplant patients: a literature review A Burlacu, A Iftene, D Jugrin, IV Popa, PM Lupu, C Vlad, A Covic BioMed research international 2020 (1), 9867872, 2020 | 56 | 2020 |
| Determinants of the hesitancy toward COVID-19 vaccination in Eastern European countries and the relationship with health and vaccine literacy: a literature review AD Popa, AI Enache, IV Popa, SA Antoniu, RA Dragomir, A Burlacu Vaccines 10 (5), 672, 2022 | 46 | 2022 |
| “A chain only as strong as its weakest link”: an up-to-date literature review on the bidirectional interaction of pulmonary fibrosis and COVID-19 R Crisan-Dabija, CA Pavel, IV Popa, A Tarus, A Burlacu Journal of proteome research 19 (11), 4327-4338, 2020 | 35 | 2020 |
| Influencing cardiovascular outcomes through heart rate variability modulation: A systematic review A Burlacu, C Brinza, IV Popa, A Covic, M Floria Diagnostics 11 (12), 2198, 2021 | 34 | 2021 |
| Coronary revascularization during treatment of severe aortic stenosis: A meta‐analysis of the complete percutaneous approach (PCI plus TAVR) versus the complete surgical … A Tarus, G Tinica, A Bacusca, B Artene, IV Popa, A Burlacu Journal of cardiac surgery 35 (8), 2009-2016, 2020 | 29 | 2020 |
| Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES) MA Badea, VL Drug, M Dranga, O Gavrilescu, G Stefanescu, I Popa, ... Metabolic brain disease 31, 1463-1471, 2016 | 29 | 2016 |
| Pandemic lockdown, healthcare policies and human rights: integrating opposed views on COVID-19 public health mitigation measures A Burlacu, R Crisan-Dabija, A Covic, C Raiu, I Mavrichi, IV Popa, ... IMR Press, 2020 | 26 | 2020 |
| Unpuzzling COVID-19 prothrombotic state: are preexisting thrombophilic risk profiles responsible for heterogenous thrombotic events? A Burlacu, S Genovesi, IV Popa, R Crisan-Dabija Clinical and Applied Thrombosis/Hemostasis 26, 1076029620952884, 2020 | 20 | 2020 |
| Magnesium—A potential key player in inflammatory bowel diseases? GE Gilca-Blanariu, A Trifan, M Ciocoiu, IV Popa, A Burlacu, GG Balan, ... Nutrients 14 (9), 1914, 2022 | 18 | 2022 |
| Curbing the AI-induced enthusiasm in diagnosing COVID-19 on chest X-rays: the present and the near-future A Burlacu, R Crisan-Dabija, IV Popa, B Artene, V Birzu, M Pricop, ... MedRxiv, 2020.04. 28.20082776, 2020 | 18 | 2020 |
| Halotherapy—An ancient natural ally in the management of Asthma: A comprehensive review R Crisan-Dabija, IG Sandu, IV Popa, DV Scripcariu, A Covic, A Burlacu Healthcare 9 (11), 1604, 2021 | 17 | 2021 |
| Gut Microbiota Changes in Inflammatory Bowel Diseases and Ankylosing Spondylitis. A Cardoneanu, C Mihai, E Rezus, A Burlui, I Popa, CC Prelipcean Journal of Gastrointestinal & Liver Diseases 30 (1), 2021 | 15 | 2021 |
| Determinants of acute kidney injury after cardiac surgery: a systematic review G Tinica, C Brinza, A Covic, IV Popa, A Tarus, AE Bacusca, A Burlacu Reviews in Cardiovascular Medicine 21 (4), 601-610, 2020 | 14 | 2020 |
| A machine learning model accurately predicts ulcerative colitis activity at one year in patients treated with anti-tumour necrosis factor α agents IV Popa, A Burlacu, C Mihai, CC Prelipcean Medicina 56 (11), 628, 2020 | 14 | 2020 |
| Pulmonary arterial hypertension and adverse outcomes after kidney transplantation: a systematic review and meta-analysis C Brinza, A Covic, AE Stefan, M Floria, IV Popa, DV Scripcariu, A Burlacu Journal of Clinical Medicine 11 (7), 1944, 2022 | 13 | 2022 |
| Computational models used to predict cardiovascular complications in chronic kidney disease patients: a systematic review A Burlacu, A Iftene, IV Popa, R Crisan-Dabija, C Brinza, A Covic Medicina 57 (6), 538, 2021 | 13 | 2021 |
| Ischemic heart disease in patients with inflammatory bowel disease: risk factors, mechanisms and prevention AE Jucan, O Gavrilescu, M Dranga, IV Popa, BM Mihai, CC Prelipcean, ... Life 12 (8), 1113, 2022 | 12 | 2022 |
| Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients O Gavrilescu, CC Prelipcean, M Dranga, IV Popa, C Mihai Medicina 58 (5), 562, 2022 | 11 | 2022 |
| COVID‐19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges IV Popa, M Diculescu, C Mihai, C Cijevschi-Prelipcean, A Burlacu Gastroenterology Research and Practice 2020 (1), 1918035, 2020 | 11 | 2020 |
